Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

the ENHANCE trial. (Announced Jan. 25, 2008)

-- Announced FDA acceptance for review of the Peg-IFN (peginterferon alfa-

2b) supplemental Biologics License Application, granted Priority Review

status for the adjuvant treatment of patients with Stage III melanoma.

(Announced Jan. 31, 2008)

-- Reported that the antifungal agent NOXAFIL (posaconazole) Oral

Suspension had received an A-1 recommendation (highest rating) for the

prevention of invasive Aspergillus infections in certain high-risk

patients in the latest Treatment of Aspergillosis Clinical Practice

Guidelines of the Infectious Diseases Society of America. (Announced

Jan. 31, 2008)

-- Gained FDA approval of ASMANEX TWISTHALER (mometasone furoate

inhalation powder) for the maintenance treatment of asthma as a

preventive therapy in patients 4 to 11 years of age. (Announced Feb.

4, 2008)

-- Announced final results of a Phase II clinical study showing that

vicriviroc, an investigational CCR5 antagonist, demonstrated potent and

sustained viral suppression through 48 weeks of therapy in treatment-

experienced HIV-infected patients, when administered once-daily as a

single tablet in combination with an optimized ritonavir-boosted

protease inhibitor-containing antiretroviral regimen. (Announced Feb.

6, 2008)

Fourth Quarter 2007 Conference Call and Webcast

Schering-Plough will conduct a conference call today at 8 a.m. (EST) to review the 2007 fourth quarter and full-year results. To listen live to the call, dial 1-877-565-9664 or 1-706-634-5003 and enter conference ID #26183610. A replay of the call will be available beginning later today through 5 p.m. on March 11. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID #26183610. A live audio webcast of the conference call also will be availab
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Paula, CA (PRWEB) September 15, 2014 ... long term implantable silicones for the medical device ... responsive silicone gel for the implantable medical device ... a unique crosslink technology delivering a silicone gel ... The Dual Matrix technology consists of two ...
(Date:9/15/2014)... 15 septembre 2014 La deuxième édition ... (semaine internationale sur la sensibilisation au plasma) ... conjointe de la Plasma Protein Therapeutics Association ... , l,IPAW vise à : , ... la collecte du plasma-aphérèse , Reconnaître la ...
(Date:9/15/2014)... 2014  The second annual International Plasma Awareness ... joint initiative of the Plasma Protein Therapeutics Association ... is designed to: , Raise global awareness ... of plasma donors in saving and improving lives ... rare diseases Member companies are planning ...
(Date:9/14/2014)... (PRWEB) September 15, 2014 UMBC’s ... held on Tuesday, October 21, 2014, from 12:00 to ... of the program’s innovative curriculum and practice-oriented instruction, designed ... graduate degree can help advance their career in the ... RSVP online . , About UMBC’s Biotechnology Graduate ...
Breaking Biology Technology:Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 2International Plasma Awareness Week To Celebrate Donors And Spotlight Rare Diseases 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... ... management, NEW ... CAXG), which has the largest,manufacturing facility and product pipeline for highly ... China,State Food & Drug Administration (SFDA) granted the Company the designated,manufacturer ...
... ROCKVILLE, Md., Nov. 26 Human Genome,Sciences, Inc. (Nasdaq: ... the,Piper Jaffray 19th Annual Health Care Conference will be ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ), A member of ... of the company on Wednesday, November 28, 2007 at ...
... Ability to Integrate with Multiple Disparate PACS ... ... Turnaround, CHICAGO, Nov. 26 RSNA Booth #5924 ... connectivity and,interoperability between diagnostic acquisition devices, PACS, HIS, RIS,and ...
Cached Biology Technology:China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 4E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 2E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 3
(Date:9/15/2014)... Earth for the first 500 million years after it ... day, complete with oceans, continents and active crustal plates. ... called the Hadean, has gained substantial new support from ... more than 4 billion years ago with those formed ... possible geological analog for early Earth. , The study ...
(Date:9/15/2014)... of the cheetah: The big predator is the fastest land ... just a few seconds. As it ramps up to top ... it reaches a full gallop. , Now MIT researchers have ... a robotic cheetah a sleek, four-legged assemblage of gears, ... its feline counterpart. The team recently took the robot for ...
(Date:9/15/2014)... wild, domesticated, and domesticated-wild hybridized populations of ... that within 5 to 11 generations, selection ... populations that hybridized with domesticated populations. , ... evidence that natural selection, over time, removes ... as a result of increased genetic diversity. ...
Breaking Biology News(10 mins):Early Earth less hellish than previously thought 2Early Earth less hellish than previously thought 3Run, cheetah, run 2Run, cheetah, run 3
... a multi-institutional study led by Cincinnati Childrens Hospital ... stubborn solid tumor cancers neuroblastoma and peripheral ... inserting instructions to inhibit tissue growth into an ... the February 15 Cancer Research. Malignant ...
... a one-celled, planktonic marine organism, reported today (Thursday, ... telling scientists about the evolutionary changes that accompanied ... animals like ourselves. In the Nature paper ... week, University of California, Berkeley, biologists Nicole King, ...
... the ideal environmentally friendly energy source, it would be a ... that does not pollute our air when burned. That is ... in a new program that uses bacteria and sunlight to ... The project is one of the first to ...
Cached Biology News:Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors 2Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4Project focuses on production of hydrogen from bacteria and sunlight 2Project focuses on production of hydrogen from bacteria and sunlight 3Project focuses on production of hydrogen from bacteria and sunlight 4
Human Glypican 2 Biotinylated Affinity Purified PAb...
Human Contactin-2/TAG1 Affinity Purified Polyclonal Ab...
Tachykinin (H-2)...
Human BMP 2 Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Biology Products: